Cargando…
Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation
BACKGROUND: In a previously published pilot study we explored the performance of microarrays in predicting clinical behaviour of ovarian tumours. For this purpose we performed microarray analysis on 20 patients and estimated that we could predict advanced stage disease with 100% accuracy and the res...
Autores principales: | Gevaert, Olivier, De Smet, Frank, Van Gorp, Toon, Pochet, Nathalie, Engelen, Kristof, Amant, Frederic, De Moor, Bart, Timmerman, Dirk, Vergote, Ignace |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259320/ https://www.ncbi.nlm.nih.gov/pubmed/18211668 http://dx.doi.org/10.1186/1471-2407-8-18 |
Ejemplares similares
-
Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review
por: Dumont, Sander, et al.
Publicado: (2019) -
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
por: Van Gorp, T, et al.
Publicado: (2011) -
Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS
por: Van Gorp, Toon, et al.
Publicado: (2012) -
Balancing false positives and false negatives for the detection of differential expression in malignancies
por: De Smet, F, et al.
Publicado: (2004) -
Reply: The performance of the risk of ovarian malignancy algorithm
por: Van Gorp, T, et al.
Publicado: (2011)